S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months

VolitionRx (VNRX) News Today

$0.64
-0.02 (-3.09%)
(As of 12/8/2023 08:58 PM ET)
Compare
Today's Range
$0.63
$0.70
50-Day Range
$0.62
$0.88
52-Week Range
$0.58
$2.74
Volume
137,000 shs
Average Volume
150,152 shs
Market Capitalization
$50.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50
SourceHeadline
finance.yahoo.com logoVolition Presents at the 5th Annual Congress of the International Liquid Biopsy Society
finance.yahoo.com - November 17 at 1:08 PM
proactiveinvestors.com logoVolitionRx to host Q3 earnings call on November 15
proactiveinvestors.com - November 8 at 2:08 PM
markets.businessinsider.com logoVolitionRX’s Innovative Cancer Detection Platform: A Promising Investment – An Analyst’s Perspective
markets.businessinsider.com - October 28 at 11:59 PM
marketbeat.com logoVolitionRx Limited (NYSE:VNRX) Director Martin Charles Faulkes Acquires 9,716 Shares
marketbeat.com - September 1 at 11:16 AM
Get VolitionRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter.



VNRX Media Mentions By Week

VNRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VNRX
News Sentiment

0.00

0.53

Average
Medical
News Sentiment

VNRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VNRX Articles
This Week

0

0

VNRX Articles
Average Week

Get VolitionRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:VNRX) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -